Equestrian Sports New Zealand is considering its position on the International Equestrian Federation's new drugs proposal.
The FEI announced this week
a drugs regime to go before national federations when they gather in Taiwan in November.
The new list effectively buries an earlier controversial proposal to allow levels of certain non-steroidal anti-inflammatory drugs (NSAIDs) in competition horses.
The FEI's List Group has proposed allowing the use of drugs such as phenylbutazone and flunixin between competitions, but will not permit any detectable levels during competition.
The FEI believes the new proposal will not pose any potential threat to horse welfare and would maintain a zero-tolerance stance in competition.
It acknowledged, in announcing the list, that evidence presented at the recent NSAID congress in Lausanne was contradictory on the use of NSAIDs in competition and that it could not exclude a welfare threat to horses.
Equestrian Sports New Zealand chief executive Jim Ellis told Horsetalk that the organisation was still considering its stance on the proposal.
"I'm in discussion with relevant officials within the organisation on the stance that we will take in Taiwan," he said.
Facebook
Twitter
HOME SITES 
